Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

[Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks].

Hinoda Y.

Rinsho Byori. 2012 Oct;60(10):967-8. Japanese.

PMID:
23323461
2.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
3.

Special report: multiple molecular testing of cancers to identify targeted therapies.

BlueCross BlueShield Association.

Technol Eval Cent Assess Program Exec Summ. 2013 Jun;28(1):1-2. No abstract available.

PMID:
23865106
4.

[Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].

Ludwig WD.

Z Evid Fortbild Qual Gesundhwes. 2012;106(1):11-22. doi: 10.1016/j.zefq.2011.12.001. Epub 2012 Jan 10. Review. German.

PMID:
22325103
5.

International Cancer Conference: targeted therapies boom expected in 3-5 years.

Gethins M.

J Natl Cancer Inst. 2011 Oct 19;103(20):1491-3. doi: 10.1093/jnci/djr414. Epub 2011 Oct 4. No abstract available. Erratum in: J Natl Cancer Inst. 2012 Feb 8;104(3):177.

PMID:
21972228
6.

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.

Savonarola A, Palmirotta R, Guadagni F, Silvestris F.

Pharmacogenomics J. 2012 Aug;12(4):277-86. doi: 10.1038/tpj.2012.28. Epub 2012 Jul 3. Review.

PMID:
22760589
7.

Genomics, personalized medicine and cancer practice.

Dancey J.

Clin Biochem. 2012 Apr;45(6):379-81. doi: 10.1016/j.clinbiochem.2012.03.003. No abstract available.

PMID:
22424082
8.

Biomarkers as molecular targets of drug interventions.

Smith JJ, Dunn BK.

Semin Oncol Nurs. 2012 May;28(2):109-15. doi: 10.1016/j.soncn.2012.03.004. Review.

PMID:
22542318
9.

Cancer pharmacogenomics: early promise, but concerted effort needed.

McLeod HL.

Science. 2013 Mar 29;339(6127):1563-6. doi: 10.1126/science.1234139. Review.

10.

Molecular classification and drug response prediction in cancer.

Creighton CJ.

Curr Drug Targets. 2012 Nov;13(12):1488-94. Review.

PMID:
22974392
11.

Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer.

Rothschild SI, Gautschi O, Lara PN Jr, Mack PC, Gandara DR.

Curr Opin Oncol. 2011 Mar;23(2):150-7. doi: 10.1097/CCO.0b013e328341ee38. Review.

PMID:
21119513
12.

Assessing cancer with a blood draw.

Azvolinsky A.

J Natl Cancer Inst. 2012 Dec 5;104(23):1774-5. doi: 10.1093/jnci/djs495. No abstract available.

PMID:
23213181
13.

Array-based pharmacogenomics of molecular-targeted therapies in oncology.

Sanoudou D, Mountzios G, Arvanitis DA, Pectasides D.

Pharmacogenomics J. 2012 Jun;12(3):185-96. doi: 10.1038/tpj.2011.53. Epub 2012 Jan 17. Review.

PMID:
22249357
14.

Impact of tumor sequencing on the use of anticancer drugs.

Thomas F, Desmedt C, Aftimos P, Awada A.

Curr Opin Oncol. 2014 May;26(3):347-56. doi: 10.1097/CCO.0000000000000078. Review.

PMID:
24709974
15.

Personalizing oncology: perspectives and prospects.

Mendelsohn J.

J Clin Oncol. 2013 May 20;31(15):1904-11. doi: 10.1200/JCO.2012.45.3605. Epub 2013 Apr 15. Review.

PMID:
23589547
16.

Individualized targeted therapy for glioblastoma: fact or fiction?

Weller M, Stupp R, Hegi M, Wick W.

Cancer J. 2012 Jan-Feb;18(1):40-4. doi: 10.1097/PPO.0b013e318243f6c9. Review.

PMID:
22290256
17.

Functional drug-gene interactions in lung cancer.

Smida M, Nijman SM.

Expert Rev Mol Diagn. 2012 Apr;12(3):291-302. doi: 10.1586/erm.12.16. Review.

PMID:
22468819
18.

Personalized-medicine trials on the rise.

Benowitz S.

J Natl Cancer Inst. 2012 Oct 3;104(19):1425-6. doi: 10.1093/jnci/djs432. Epub 2012 Sep 24. No abstract available.

PMID:
23008496
19.

Advances in treatment of lung cancer with targeted therapy.

Cagle PT, Chirieac LR.

Arch Pathol Lab Med. 2012 May;136(5):504-9. doi: 10.5858/arpa.2011-0618-RA. Review.

PMID:
22540298
20.

[Targeted biological treatment of solid tumours].

Petruzelka L.

Vnitr Lek. 2011 Sep;57(9):740-4. Review. Czech.

PMID:
21957767

Supplemental Content

Support Center